22:44:23 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ARTV - ARTIVA BIOTHERAPEUTICS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ARTV - Q0.61.60·2.451.41.61+0.021.378.2975121.61  1.64  1.6017.305  1.4715:29:44May 2815 min RT 2¢

Recent Trades - Last 10 of 512
Time ETExPriceChangeVolume
15:29:44Q1.640.052
15:28:23Q1.640.051
15:28:17Q1.640.0513
15:28:17Q1.640.051
15:28:17Q1.640.051
15:28:17Q1.640.051
15:28:17Q1.640.051
14:44:10Q1.640.059
14:44:10Q1.640.051
14:26:52Q1.60160.011670

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-28 16:05U:ARTVNews ReleaseArtiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
2025-05-13 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK(TM) in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
2025-05-08 08:00U:ARTVNews ReleaseArtiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
2025-04-28 16:35U:ARTVNews ReleaseArtiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK(TM) in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
2025-04-08 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
2025-03-31 16:05U:ARTVNews ReleaseArtiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
2025-03-24 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
2025-02-20 16:05U:ARTVNews ReleaseArtiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
2025-01-29 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
2024-11-12 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
2024-11-11 16:05U:ARTVNews ReleaseArtiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
2024-10-22 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
2024-09-10 16:05U:ARTVNews ReleaseArtiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
2024-08-29 16:05U:ARTVNews ReleaseArtiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
2024-07-18 19:09U:ARTVNews ReleaseArtiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering